Skip to main content

and
  1. No Access

    Article

    Allogeneic hematopoietic SCT for alpha-mannosidosis: an analysis of 17 patients

    Alpha-mannosidosis is a rare lysosomal storage disease. Hematopoietic SCT (HSCT) is usually recommended as a therapeutic option though reports are anecdotal to date. This retrospective multi institutional anal...

    M Mynarek, J Tolar, M H Albert, M L Escolar, J J Boelens in Bone Marrow Transplantation (2012)

  2. No Access

    Article

    Improving outcome through two decades in childhood ALL in the Nordic countries: the impact of high-dose methotrexate in the reduction of CNS irradiation

    In this population-based material from the five Nordic countries (Denmark, Finland, Iceland, Norway and Sweden), 2860 children below 15 years of age were diagnosed with acute lymphoblastic leukemia (ALL) from ...

    G Gustafsson, K Schmiegelow, E Forestier, N Clausen, A Glomstein, G Jonmundsson in Leukemia (2000)

  3. Article

    IDENTIFICATION OF MICRODELETIONS SPANNING THE DIAMOND-BLACKFAN ANEMIA (DBA) LOCUS ON 19Q13 AND EVIDENCE FOR GENETIC HETEROGENEITY

    P Gustavsson, E Garelli, N Draptchinskaia, S Ball, T N Willing in Pediatric Research (1999)

  4. No Access

    Article

    Allogeneic bone marrow transplantation in second remission of childhood acute lymphoblastic leukemia: a population-based case control study from the Nordic countries

    This study compares allogeneic BMT with conventional chemotherapy for childhood ALL in second remission. Seventy-five children were transplanted between July 1981 and December 1995. For each patient two contro...

    H Schroeder, G Gustafsson, UM Saarinen-Pihkala, A Glomstein in Bone Marrow Transplantation (1999)

  5. Article

    QUALITY OF LIFE IN PATIENTS TREATED WITH A NATIONAL ALL PROTOCOL 15-10 YEARS EARLIER: IDM/HDM AND LATE EFFECTS? 123

    P J Moe, A Glomstein, B Madsen, A Holen in Pediatric Research (1997)